Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

MEDI: FIRST QUARTER FINANCIAL RESULTS 2023

Medistim
Sales for the first quarter ended at MNOK 129.3 (MNOK 116.1), an increase of
11.3%. The Vascular business segment continues the positive development and
grows at 21.5% in NOK, currency neutral 8.8% growth. The Imaging products grow
at 9.4% in NOK with a currency neutral decline of 3.7%. Currency neutral growth
of own products was 2.5%. Operating profit (EBIT) for the quarter ended at MNOK
33.5 (MNOK 33.4). Medistim establishes direct sales organizations in both Canada
and China this quarter. Cash position is down MNOK 3.3 due to inventory build up
and timing of sales for the quarter. The General Meeting decided a dividend of
NOK 4.50 per share, a total dividend payment of MNOK 82.2
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.